EssilorLuxottica Société anonyme Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
EssilorLuxottica Société anonyme has been growing earnings at an average annual rate of 29.2%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 13.2% per year. EssilorLuxottica Société anonyme's return on equity is 6.1%, and it has net margins of 8.9%.
Wichtige Informationen
29.2%
Wachstumsrate der Gewinne
27.1%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 21.6% |
| Wachstumsrate der Einnahmen | 13.2% |
| Eigenkapitalrendite | 6.1% |
| Netto-Marge | 8.9% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Calculating The Intrinsic Value Of EssilorLuxottica Société anonyme (EPA:EL)
Nov 03
Investors Interested In EssilorLuxottica Société anonyme's (EPA:EL) Earnings
Oct 21Is EssilorLuxottica Société anonyme (EPA:EL) Using Too Much Debt?
Sep 23Is EssilorLuxottica Société anonyme (EPA:EL) Potentially Undervalued?
Aug 27EssilorLuxottica Société anonyme (EPA:EL) Is Looking To Continue Growing Its Returns On Capital
Aug 13Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Jul 27EssilorLuxottica Société anonyme's (EPA:EL) Shares May Have Run Too Fast Too Soon
Jul 12Returns Are Gaining Momentum At EssilorLuxottica Société anonyme (EPA:EL)
May 14At €203, Is It Time To Put EssilorLuxottica Société anonyme (EPA:EL) On Your Watch List?
Apr 29Should You Be Adding EssilorLuxottica Société anonyme (EPA:EL) To Your Watchlist Today?
Apr 16Pinning Down EssilorLuxottica Société anonyme's (EPA:EL) P/E Is Difficult Right Now
Apr 04These 4 Measures Indicate That EssilorLuxottica Société anonyme (EPA:EL) Is Using Debt Reasonably Well
Mar 23Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Feb 18Getting In Cheap On EssilorLuxottica Société anonyme (EPA:EL) Might Be Difficult
Jan 01With EPS Growth And More, EssilorLuxottica Société anonyme (EPA:EL) Makes An Interesting Case
Dec 17Is There Now An Opportunity In EssilorLuxottica Société anonyme (EPA:EL)?
Dec 04Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Nov 19Does EssilorLuxottica Société anonyme (EPA:EL) Have A Healthy Balance Sheet?
Sep 25With EPS Growth And More, EssilorLuxottica Société anonyme (EPA:EL) Makes An Interesting Case
Sep 09Should You Think About Buying EssilorLuxottica Société anonyme (EPA:EL) Now?
Aug 24An Intrinsic Calculation For EssilorLuxottica Société anonyme (EPA:EL) Suggests It's 21% Undervalued
Aug 11Does EssilorLuxottica Société anonyme (EPA:EL) Deserve A Spot On Your Watchlist?
Jun 05What Is EssilorLuxottica Société anonyme's (EPA:EL) Share Price Doing?
May 10Is EssilorLuxottica Société anonyme (EPA:EL) A Risky Investment?
Apr 25Here's Why We Think EssilorLuxottica Société anonyme (EPA:EL) Might Deserve Your Attention Today
Feb 21Is It Time To Consider Buying EssilorLuxottica Société anonyme (EPA:EL)?
Jan 25A Look At The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Jan 10These 4 Measures Indicate That EssilorLuxottica Société anonyme (EPA:EL) Is Using Debt Safely
Nov 29Here's Why We Think EssilorLuxottica Société anonyme (EPA:EL) Is Well Worth Watching
Nov 14At €155, Is EssilorLuxottica Société anonyme (EPA:EL) Worth Looking At Closely?
Oct 17Are Investors Undervaluing EssilorLuxottica Société anonyme (EPA:EL) By 36%?
Oct 04Is EssilorLuxottica Société anonyme (EPA:EL) A Risky Investment?
Aug 25Do EssilorLuxottica Société anonyme's (EPA:EL) Earnings Warrant Your Attention?
Aug 11Is It Time To Consider Buying EssilorLuxottica Société anonyme (EPA:EL)?
Jul 01Is EssilorLuxottica Société anonyme (EPA:EL) Trading At A 29% Discount?
Jun 13Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie EssilorLuxottica Société anonyme Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 25,834 | 2,293 | 12,141 | 602 |
| 31 Mar 24 | 25,615 | 2,291 | 12,067 | 598 |
| 31 Dec 23 | 25,395 | 2,289 | 11,993 | 593 |
| 30 Sep 23 | 25,373 | 2,314 | 11,997 | 604 |
| 30 Jun 23 | 25,351 | 2,339 | 12,000 | 614 |
| 31 Mar 23 | 24,923 | 2,246 | 11,821 | 607 |
| 31 Dec 22 | 24,494 | 2,152 | 11,642 | 600 |
| 30 Sep 22 | 23,770 | 1,960 | 11,396 | 588 |
| 30 Jun 22 | 23,046 | 1,768 | 11,150 | 575 |
| 31 Mar 22 | 21,433 | 1,608 | 10,193 | 577 |
| 31 Dec 21 | 19,820 | 1,448 | 9,235 | 579 |
| 30 Sep 21 | 18,394 | 1,400 | 8,333 | 575 |
| 30 Jun 21 | 16,967 | 1,351 | 7,430 | 571 |
| 31 Mar 21 | 15,698 | 718 | 7,240 | 562 |
| 31 Dec 20 | 14,429 | 85 | 7,049 | 552 |
| 30 Sep 20 | 14,637 | 40 | 7,209 | 551 |
| 30 Jun 20 | 14,844 | -6 | 7,369 | 550 |
| 31 Mar 20 | 16,117 | 536 | 7,727 | 549 |
| 31 Dec 19 | 17,390 | 1,077 | 8,085 | 548 |
| 30 Sep 19 | 16,215 | 1,151 | 7,629 | 489 |
| 30 Jun 19 | 15,040 | 1,224 | 7,172 | 430 |
| 31 Mar 19 | 12,937 | 1,154 | 6,108 | 310 |
| 31 Dec 18 | 10,833 | 1,083 | 5,044 | 190 |
| 30 Sep 18 | 10,364 | 1,132 | 5,057 | 85 |
| 30 Jun 18 | 9,894 | 1,181 | 5,069 | -21 |
| 31 Mar 18 | 9,539 | 1,111 | 4,605 | 20 |
| 31 Dec 17 | 9,184 | 1,040 | 4,141 | 60 |
| 30 Sep 17 | 8,288 | 913 | 3,011 | 138 |
| 30 Jun 17 | 7,391 | 786 | 1,881 | 216 |
| 31 Mar 17 | 7,253 | 800 | 1,848 | 215 |
| 31 Dec 16 | 7,115 | 813 | 1,814 | 214 |
| 30 Sep 16 | 7,003 | 799 | 1,799 | 216 |
| 30 Jun 16 | 6,891 | 785 | 1,783 | 218 |
| 31 Mar 16 | 6,804 | 771 | 1,755 | 216 |
| 31 Dec 15 | 6,716 | 757 | 1,727 | 214 |
| 30 Sep 15 | 6,507 | 688 | 1,664 | 208 |
| 30 Jun 15 | 6,298 | 618 | 1,601 | 202 |
| 31 Mar 15 | 5,984 | 774 | 1,504 | 195 |
| 31 Dec 14 | 5,670 | 929 | 1,406 | 188 |
| 30 Sep 14 | 5,470 | 956 | 1,326 | 181 |
| 30 Jun 14 | 5,269 | 982 | 1,245 | 173 |
| 31 Mar 14 | 5,167 | 788 | 1,211 | 169 |
| 31 Dec 13 | 5,065 | 593 | 1,177 | 164 |
Qualität der Erträge: EL has high quality earnings.
Wachsende Gewinnspanne: EL's current net profit margins (8.9%) are lower than last year (9.2%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: EL's earnings have grown significantly by 29.2% per year over the past 5 years.
Beschleunigtes Wachstum: EL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: EL had negative earnings growth (-2%) over the past year, making it difficult to compare to the Medical Equipment industry average (12.7%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: EL's Return on Equity (6.1%) is considered low.